| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/22/1997 | EP0754688A2 Dioxolane intermediates |
| 01/22/1997 | EP0754687A1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 01/22/1997 | EP0754466A2 Osteoinduction substance, method of manufacturing the same, and bone filling material including the same |
| 01/22/1997 | EP0754455A1 Pharmaceutical compositions based on aminomethylindoles and their therapeutical application as neuroprotectors in parkinson and alzheimer diseases |
| 01/22/1997 | EP0754454A1 Cholinesterase activator |
| 01/22/1997 | EP0754447A1 Skin-cosmetic composition |
| 01/22/1997 | EP0754242A1 OLIGONUCLEOTIDE N3'$m(7)P5' PHOSPHORAMIDATES: SYNTHESIS AND COMPOUNDS; HYBRIDIZATION AND NUCLEASE RESISTANCE PROPERTIES |
| 01/22/1997 | EP0754234A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
| 01/22/1997 | EP0754189A1 Receptor modulating agents and methods relating thereto |
| 01/22/1997 | EP0754187A1 Growth arrest homeobox gene |
| 01/22/1997 | EP0754176A1 Novel carbamates and ureas as modifiers of multi-drug resistance |
| 01/22/1997 | EP0754173A1 Method for purifying diacetyl rhein |
| 01/22/1997 | EP0754060A1 NEW COMBINATION OF A $g(b)-RECEPTOR BLOCKER AND A LOCAL ANAESTHETIC |
| 01/22/1997 | EP0754052A1 Antiviral wound healing composition containing a pyruvate, an antioxidant, a mixture of fatty acids and an antiviral compound |
| 01/22/1997 | EP0754048A1 Treatment of partial growth hormone insensitivity syndrome |
| 01/22/1997 | EP0754043A1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 01/22/1997 | EP0754042A1 Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
| 01/22/1997 | EP0754041A1 Novel substituted tryptamines, phenalkylamines and related compounds |
| 01/22/1997 | EP0754039A1 Methods of using iron chelating compounds to reduce free radical damage in mammals |
| 01/22/1997 | EP0677048B1 Cyclic sulfone containing retroviral protease inhibitors |
| 01/22/1997 | EP0656898B1 Pyridopyrimidinone antianginal agents |
| 01/22/1997 | EP0593419B1 Inhibitors for glycosaminosyl transferase-v |
| 01/22/1997 | EP0546007B1 Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients |
| 01/22/1997 | CN1141045A Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene) cytidine |
| 01/22/1997 | CN1141043A Non-peptide tachykinin receptor antagonists |
| 01/22/1997 | CN1141042A Enantiomerically pure (+)-liarozole |
| 01/22/1997 | CN1141033A DP-IV-serine protease inhibitors |
| 01/22/1997 | CN1140998A Compositions which inhibit apoptosis, method of purifying the compositions and uses thereof |
| 01/22/1997 | CN1140997A Vanadate compounds for the treatment of proliferative disorders metastases and drug resistant tumors |
| 01/22/1997 | CN1140994A Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 01/21/1997 | US5596106 Cannabinoid receptor antagonists |
| 01/21/1997 | US5596086 Dimers with phosphodiester linkages for hybridization to target rna or dna sequences |
| 01/21/1997 | US5596012 Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/21/1997 | US5596011 Administering a glutathione enhancing agent |
| 01/21/1997 | US5595989 Antiinflammatory agents and antidiabetic agents |
| 01/21/1997 | US5595973 Protection of hemopoietic cells during chemotherapy or radiotherapy |
| 01/21/1997 | US5595888 Recombinant methods of making gamma interferon compositions |
| 01/21/1997 | US5595744 Respiratory disease vaccine for cats |
| 01/21/1997 | US5595732 Polyethylene-protein conjugates |
| 01/21/1997 | US5595730 Lactate dehydrogenase inhibitors in cosmetic compositions |
| 01/21/1997 | CA2033249C Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures |
| 01/19/1997 | CA2154092A1 Skin-cosmetic composition |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001579A2 Somatostatin peptides |
| 01/16/1997 | WO1997001576A2 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/16/1997 | WO1997001553A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | WO1997001551A1 Pyrazole compounds and pharmaceutical compositions |
| 01/16/1997 | WO1997001549A1 Benzothiophene compounds |
| 01/16/1997 | WO1997001540A1 Integrin receptor antagonists |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | WO1997001344A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 01/16/1997 | WO1997001338A1 Pyridinone-thrombin inhibitors |
| 01/16/1997 | WO1997001336A1 Use of lamellarin-class alkaloids in methods of treatment |
| 01/16/1997 | WO1997001335A1 Di- and trivalent small molecule selectin inhibitors |
| 01/16/1997 | WO1997001275A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | DE19525598A1 Schlafmittel Sleeping pills |
| 01/16/1997 | CA2225682A1 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 01/16/1997 | CA2225255A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | CA2224516A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | CA2224437A1 Pyridinone-thrombin inhibitors |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2220991A1 Benzothiophene compounds |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/16/1997 | CA2197861A1 Phenyl peptides, method for preparing same, and pharmaceutical compositions containing said peptides |
| 01/15/1997 | EP0753580A2 Cell-specific gene therapy, using the tissue inhibitor of metalloproteinase-3 promoter |
| 01/15/1997 | EP0753526A1 Adipocyte differentiation inhibitor peptide and adipocyte differentiation inhibitor containing said peptide as active ingredient |
| 01/15/1997 | EP0753518A1 A specific crystalline form of zilpaterol hydrochloride, process for its preparation and intermediates used |
| 01/15/1997 | EP0753302A1 Osteoporosis preventing or treating agent |
| 01/15/1997 | EP0753015A1 Monoclonal antibodies recognizing tie-receptor and their use |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0753004A1 Antagonists of endothelin receptors |
| 01/15/1997 | EP0752990A1 Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
| 01/15/1997 | EP0752987A1 Pyrimidinyl derivatives as interleukin inhibitors |
| 01/15/1997 | EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 01/15/1997 | EP0752985A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 01/15/1997 | EP0752982A1 Biphenyl derivatives as 5ht1d antagonists |
| 01/15/1997 | EP0752981A1 Substituted cycloalkylamine derivatives and their use as calcium channel antagonists |
| 01/15/1997 | EP0752884A1 Method of treating auto-immune diseases using type one interferons |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752865A1 Use of substituted dextrane for treating nervous system damage, and heparane sulphate-enriched fractions |
| 01/15/1997 | EP0752864A1 Use of growth factor protecting polymers for treating inflammation |
| 01/15/1997 | EP0752863A1 Use of biopolymers for digestive tract injuries treatment |
| 01/15/1997 | EP0752858A1 Pharmaceutical preparations and medicaments for the prevention and treatment of endothelial dysfunction |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0752813A1 Inhibitors of metazoan parasite proteases |
| 01/15/1997 | EP0595995B1 Arylamidoalkyl- and arylaminoalkyl-n-hydroxyurea compounds and -n-hydroxyformamide derivatives having lipoxygenase inhibitory activity |
| 01/15/1997 | EP0478694B1 use of pirenzepine, telenzepine oder O-methoxy -sila-hexocyclium in the manufacture of a medicament for the TREATMENT AND CONTROL OF OCULAR DEVELOPMENT |
| 01/15/1997 | EP0427827B1 8-alpha-ACYLAMINO-ERGOLINES, THEIR PREPARATION AND USE AS DRUGS |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140454A Novel mercaptoacetylamido-1,3,4,5-tetrahydro-benzo|c¨ azepin-3-one disulfide derivs. useful as inhibitors of enkephalinase and ACE |
| 01/15/1997 | CN1140451A Novel indane-2-mercaptoacetylamide disulfide derivs. useful as inhibitors of enkephalinase |
| 01/15/1997 | CN1140174A Piperidine derivatives, process for preparation thereof and application thereof in therapeutics |
| 01/15/1997 | CN1140173A Novel pyrido |3,2-e¨ pyrazinones with anti-asthmatic action and processes for their manufacture |
| 01/15/1997 | CN1140167A Process for preparing substituted 2-amino tetrahydronaphthalenes and 3-aminochromanes |
| 01/15/1997 | CN1140165A Arylsulfonyl hydroxamic acid derivatives |
| 01/15/1997 | CN1140074A Medicine for adjusting human body functions and process for producing the same |